The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study.

MLA

Brill, Gherta, et al. “The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study.” Children (Basel, Switzerland), vol. 9, no. 12, Nov. 2022. EBSCOhost, https://doi.org/10.3390/children9121844.

APA

Brill, G., Manor, I., Bril Paroz, R., Ashkenazi, S., Cohen, S., Golan-Cohen, A., Green, I., Israel, A., Vinker, S., Weizman, A., & Merzon, E. (2022). The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study. Children (Basel, Switzerland), 9(12). https://doi.org/10.3390/children9121844

Chicago

Brill, Gherta, Iris Manor, Roberta Bril Paroz, Shai Ashkenazi, Shira Cohen, Avivit Golan-Cohen, Ilan Green, et al. 2022. “The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study.” Children (Basel, Switzerland) 9 (12). doi:10.3390/children9121844.